BIIB Financial Facts
Basic earnings per share attributable to Biogen Idec Inc.: 4.72Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
See Full Income Statement
Commitments and contingencies (Notes 2, 11, 16, 18 and 20): 0
Common stock, par value $0.0005 per share: 100K
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/16/26 | EPS Growth Rate | -41.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +26.4% | Revenue Growth Rate | -6.5% |
| Average % Move 1-Wk after EPS | +3.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/16/26  |
Q226 | N/A | $3.21 | N/A | N/A | $2.43B | = | N/A | N/A | ||
| 4/29/26 | Q126 | $3.57 | $2.95 | +$0.62 | $2.48B | $2.25B | = |  | | Details | |
| 2/6/26 | Q425 | $1.99 | $1.61 | +$0.38 | $2.28B | $2.21B | = | | | Details | |
| 10/30/25 | Q325 | $4.81 | $3.88 | +$0.93 | $2.53B | $2.34B | = | | | Details | |
| 7/31/25 | Q225 | $5.47 | $3.99 | +$1.48 | $2.6B | $2.32B | = | | | Details | |
| 5/1/25 | Q125 | $3.02 | $2.96 | +$0.06 | $2.43B | $2.23B | = | | | Details | |
| 2/12/25 | Q424 | $3.44 | $3.41 | +$0.03 | $2.45B | $2.41B | = | | | Details | |
| 10/30/24 | Q324 | $4.08 | $3.77 | +$0.31 | $2.47B | $2.43B | = | | | Details |
